BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 35077153)

  • 1. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
    Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
    ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
    [No Abstract]   [Full Text] [Related]  

  • 2. Polydopamine Coated PB-MnO
    Odda AH; Li H; Kumar N; Ullah N; Khan MI; Wang G; Liang K; Liu T; Pan YY; Xu AW
    Bioconjug Chem; 2020 May; 31(5):1474-1485. PubMed ID: 32286806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dual-Model Imaging Theragnostic System Based on Mesoporous Silica Nanoparticles for Enhanced Cancer Phototherapy.
    Huang C; Zhang Z; Guo Q; Zhang L; Fan F; Qin Y; Wang H; Zhou S; Ou-Yang W; Sun H; Leng X; Pan X; Kong D; Zhang L; Zhu D
    Adv Healthc Mater; 2019 Oct; 8(19):e1900840. PubMed ID: 31512403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
    Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
    Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
    Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
    Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin-Ce6-loaded polydopamine nanoparticles-based enhanced phototherapy for B16 melanoma cancer cells.
    Shinde VR; Thanekar AM; Khatun S; Buddhiraju HS; Bhattacharjee B; Rengan AK
    Nanotechnology; 2024 Apr; 35(29):. PubMed ID: 38593752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic photothermal/photodynamic suppression of prostatic carcinoma by targeted biodegradable MnO
    Zeng D; Wang L; Tian L; Zhao S; Zhang X; Li H
    Drug Deliv; 2019 Dec; 26(1):661-672. PubMed ID: 31257941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
    He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
    Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging.
    Wu K; Zhao H; Sun Z; Wang B; Tang X; Dai Y; Li M; Shen Q; Zhang H; Fan Q; Huang W
    Theranostics; 2019; 9(25):7697-7713. PubMed ID: 31695795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy.
    Wang D; Zhang N; Jing X; Zhang Y; Xu Y; Meng L
    J Mater Chem B; 2020 Sep; 8(36):8271-8281. PubMed ID: 32812996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.
    Zhang D; Wu M; Zeng Y; Wu L; Wang Q; Han X; Liu X; Liu J
    ACS Appl Mater Interfaces; 2015 Apr; 7(15):8176-87. PubMed ID: 25837008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart PdH@MnO
    Wang W; Chen C; Ying Y; Lv S; Wang Y; Zhang X; Cai Z; Gu W; Li Z; Jiang G; Gao F
    ACS Nano; 2022 Apr; 16(4):5597-5614. PubMed ID: 35315637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MnO
    Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
    J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporally Controlled Photothermal/Photodynamic and Combined Therapy for Overcoming Multidrug Resistance of Cancer by Polydopamine Nanoclustered Micelles.
    Xing Y; Ding T; Wang Z; Wang L; Guan H; Tang J; Mo D; Zhang J
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13945-13953. PubMed ID: 30907570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma.
    Wang C; Cheng X; Peng H; Zhang Y
    Nanoscale Res Lett; 2022 Sep; 17(1):92. PubMed ID: 36125619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Oxygen Species and Folate Receptor-Targeted Nanophotosensitizers Composed of Folic Acid-Conjugated and Poly(ethylene glycol)-Chlorin e6 Tetramer Having Diselenide Linkages for Targeted Photodynamic Treatment of Cancer Cells.
    Yang SW; Jeong YI; Kook MS; Kim BH
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
    Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
    J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
    Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
    Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
    Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
    Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.